Taltz 80 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB26FFGBQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,422
Award facts
- Contract value 100% obligated
- $15,422.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,422.41 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on November 3, 2025, with completion targeted for November 4, 2025. This firm fixed-price contract represents a pediatric delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award utilizes no set-aside designation and reflects competitive procurement practices. TALTZ (ixekizumab) is a prescription biologic medication used to treat autoimmune inflammatory conditions, supplied as a pre-filled autoinjector for direct administration by military healthcare beneficiaries.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal medical procurement systems, particularly the Defense Health Agency and military healthcare networks. The company maintains an extensive portfolio of pharmaceutical products and medical supplies delivered through its comprehensive DLA prime vendor contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's ongoing role in supporting military medical supply chain operations and demonstrates the DLA's reliance on established prime vendor relationships to fulfill specialized pharmaceutical requirements efficiently.
Quick answers
Who was awarded contract SPE2DB26FFGBQ?
SPE2DB26FFGBQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FFGBQ worth?
The government has obligated $15,422 on SPE2DB26FFGBQ.
Is contract SPE2DB26FFGBQ an order under another contract?
Yes. SPE2DB26FFGBQ is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB26FFGBQ competed?
The extent of competition for SPE2DB26FFGBQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award